Effect of NMT inhibitors on <i>C. elegans</i> growth. by Brendan D. Galvin (592211)

“…<p>Wild-type <i>C. elegans</i> were grown on NGM plates seeded with OP50 <i>E. coli</i>. Compound screening (DDD85646 and DDD100870) commenced with L4-staged worms placed into a well of a sterile 96-well micro titer plate (Falcon 3072) containing a 100 µL suspension of previously frozen HB101 <i>E. coli</i> bacteria in S medium. …”

Column-based Technology for CD9-HPLC Immunoaffinity Isolation of Serum Extracellular Vesicles by Jianhui Zhu (678784)

“…Herein we have developed a column-based CD9-antibody-immobilized high-performance liquid chromatography immunoaffinity chromatography­(CD9-HPLC-IAC) technology for EV isolation from a microliter scale of serum for downstream proteomic analysis. …”

mPEG PV1-Fab’ dampens IFN-γ production by CD4⁺ T lymphocytes. by Pedro Henrique Papotto (791904)

Suppressed expression of <i>CDS1</i> and <i>CDS2</i> resulted in the defective embryonic development. by Xin-Qiao Du (13150022)

Immunohistochemical labeling for thrombospondin 1. by Harry A. Quigley (695817)

Basic characteristics included in the study. by Juan Gu (288925)

“…A period of 10–20 years since the last birth also showed a decreased risk (OR=0.867; 95% CI:0.747–1.007), whereas more than 20 years since the last birth was associated with an increased risk (OR = 1.304; 95% CI: 1.111–1.530).…”

Publication bias of the risk of all groups. by Juan Gu (288925)

“…A period of 10–20 years since the last birth also showed a decreased risk (OR=0.867; 95% CI:0.747–1.007), whereas more than 20 years since the last birth was associated with an increased risk (OR = 1.304; 95% CI: 1.111–1.530).…”

Study selection process. by Juan Gu (288925)

“…A period of 10–20 years since the last birth also showed a decreased risk (OR=0.867; 95% CI:0.747–1.007), whereas more than 20 years since the last birth was associated with an increased risk (OR = 1.304; 95% CI: 1.111–1.530).…”

Intermittent Heat Shocks Can Reduce Methanogenesis and Increase Generation of Longer-Chain Volatile Fatty Acids in Anaerobic Bioreactors by Hezhou Ding (14242293)

“…The relative abundances of putative chain-elongating bacteria increased and those of syntrophic acetate-forming bacteria decreased when the HSs were applied. Our findings show that intermittent HSs may provide a chemical-free methanogen-specific strategy to improve the production of VFAs, especially longer-chain species.…”

NAD⁺ metabolites regulate skin oxidative stress and inflammation. by Francisco J. Martínez-Morcillo (11663364)

Experimental study groups and the number of animals within each. by Harry A. Quigley (695817)

Primary antibodies used for histological studies and Immunoblot. by Harry A. Quigley (695817)

The process of selecting participants. by Na Li (6550)

“…Chemotherapy was found to be protective factor for OS (HR = 0.33, 95%CI: 0.30–0.37)/CSS (HR = 0.44, 95%CI: 0.39–0.50) of ovarian cancer patients, while not receiving surgery remained a risk factor. …”

C-indexes for the nomograms. by Na Li (6550)

“…Chemotherapy was found to be protective factor for OS (HR = 0.33, 95%CI: 0.30–0.37)/CSS (HR = 0.44, 95%CI: 0.39–0.50) of ovarian cancer patients, while not receiving surgery remained a risk factor. …”

Multivariable model for percent axon loss. by Harry A. Quigley (695817)

Axon loss by treatment group. by Harry A. Quigley (695817)

Tonolab Calibration. by Harry A. Quigley (695817)

Pressure—strain estimates in load—unload protocol for losartan and control groups. by Harry A. Quigley (695817)

STPKLRR is an effector secreted by AJ01 T3SS. by Fa Dai (15810913)

Low apolipoprotein A-I levels in Friedreich’s ataxia and in frataxin-deficient cells: Implications for therapy by QingQing Wang (1389630)

“…One also showed that there was no difference in serum Apo-A-I levels in FA when compared with controls. Using a highly specific stable isotope dilution mass spectrometry-based assay, we demonstrated a 21.6% decrease in serum ApoA-I in FA patients (134.8 mg/dL, n = 95) compared with non-affected controls (172.1 mg/dL, n = 95). …”